A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
SARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from silent infection to lethal disease. The role of human genetics in determining clinical response to the virus remains unclear. Studies of outliers—individuals remaining uninfected despite viral exposure and healthy young patients with life-threatening disease—present a unique opportunity to reveal human genetic determinants of infection and disease.
This article was selected by Adam Klocperk, Marketa Bloomfield, Tomáš Milota, and Anna Sediva
.